CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Human mesenchymal stem cells (MSC) indirectly preserve liver of irradiation damage
Authors
A. Athias
A. Chapel
+8 more
C. Demarquay
S. François
N.-C. Gorin
P. Gourmelon
M. Mouiseddine
A. Sache
A. Semont
M. Souidi
Publication date
1 August 2009
Publisher
'Bentham Science Publishers Ltd.'
Doi
Cite
Abstract
The present work was initiated in an effort to evaluate the potential therapeutic contribution of the infusion of MSC for the correction of liver injuries. We subjected NOD-SCID mice to a 10.5 Gy abdominal irradiation and we tested the biological and histological markers of liver injury in the absence and after infusion of expanded human MSC. Irradiation alone induced a significant elevation of transaminases (ALT and AST). Apoptosis in the endothelial layer of vessels was observed. When MSC were infused in mice, a significant decrease of transaminases was measured, and a total disappearance of apoptotic cells. MSC were not found in liver. To explain the protection of liver without MSC engraftment, we hypothesize an indirect action of MSC on the liver via the intestinal tract. Pelvic or total body irradiation induces intestinal absorption defects leading to an alteration of the enterohepatic recirculation of bile acids. This alteration induces an increase in Deoxy Cholic Acid (DCA) which is hepatoxic. In the present study, we confirm these results. DCA concentration increased approximately 2-fold after irradiation but stayed to the baseline level after MSC injection. We propose from our observations that, following irradiation, MSC infusion indirectly corrected liver dysfunction by preventing gut damage. This explanation would be consistent with the absence of MSC engraftment in liver. These results evidenced that MSC treatment of a target organ may have an effect on distant tissues. This observation comes in support to the interest for the use of MSC for cellular therapy in multiple pathologies proposed in the recent years. © Mouiseddine et al
Similar works
Full text
Available Versions
Institute for Radiation Protection and Nuclear Safety (IRSN)
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:HAL:hal-03106323v1
Last time updated on 01/03/2021
HAL-uB
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:HAL:hal-03106323v1
Last time updated on 13/01/2021
Hal-Diderot
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:HAL:hal-03106323v1
Last time updated on 14/04/2021
HAL-Inserm
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:HAL:hal-03106323v1
Last time updated on 13/01/2021
HAL Descartes
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:HAL:hal-03106323v1
Last time updated on 23/03/2021